The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter

被引:149
作者
Ventura, A
Luzi, L
Pacini, S
Baldari, CT
Pelicci, PG
机构
[1] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[2] Fdn Italiana Ric Canc, Inst Mol Oncol, I-20139 Milan, Italy
[3] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy
关键词
D O I
10.1074/jbc.M200280200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammal Shc locus encodes three overlapping isoforms (46, 52, and 66 kDa) that differ in the length of their N-terminal regions. p46/p52Shc and p66Shc have been implicated, respectively, in the cytoplasmic propagation of growth and apoptogenic signals. Levels of p66Shc expression correlate with life span duration in mice. p46Shc and p52Shc are ubiquitously expressed, whereas p66Shc is expressed in a cell lineage-specific fashion. However, the mechanisms underlying the regulation of Shc protein expression are unknown. Here we report the identification of two alternative promoters, driving the transcription of two mRNAs coding for p46/p52Shc and p66Shc. We show that treatment with an inhibitor of histone deacetylases or with a demethylating agent results in induction of p66Shc expression in cells that normally do not express this isoform but leaves the levels of the two other isoforms unchanged. Moreover, analysis of the methylation pattern of the p66Shc promoter in a panel of primary and immortalized human cells showed inverse correlation between p66Shc expression and methylation density of its promoter. These results identify histone deacetylation and cytosine methylation as the mechanisms underlying p66Shc silencing in nonexpressing cells.
引用
收藏
页码:22370 / 22376
页数:7
相关论文
共 37 条
[21]   Insulin stimulates the phosphorylation of the 66- and 52-kilodalton she isoforms by distinct pathways [J].
Kao, AW ;
Waters, SB ;
Okada, S ;
Pessin, JE .
ENDOCRINOLOGY, 1997, 138 (06) :2474-2480
[22]   Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene [J].
Kraus, J ;
Wöltje, M ;
Schönwetter, N ;
Höllt, V .
FEBS LETTERS, 1998, 428 (03) :165-170
[23]  
Lai KMV, 2000, GENE DEV, V14, P1132
[24]   Evolution of Shc functions from nematode to human [J].
Luzi, L ;
Confalonieri, S ;
Di Fiore, PP ;
Pelicci, PG .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (06) :668-674
[25]   Opposite effects of the p52(shc)/p46(shc) and p66(shc) splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway [J].
Migliaccio, E ;
Mele, S ;
Salcini, AE ;
Pelicci, G ;
Lai, KMV ;
SupertiFurga, G ;
Pawson, T ;
DiFiore, P ;
Lanfrancone, L ;
Pelicci, PG .
EMBO JOURNAL, 1997, 16 (04) :706-716
[26]   The p66shc adaptor protein controls oxidative stress response and life span in mammals [J].
Migliaccio, E ;
Giorgio, M ;
Mele, S ;
Pelicci, G ;
Reboidl, P ;
Pandolfi, PP ;
Lanfrancone, L ;
Pelicci, PG .
NATURE, 1999, 402 (6759) :309-313
[27]   Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex [J].
Nan, XS ;
Ng, HH ;
Johnson, CA ;
Laherty, CD ;
Turner, BM ;
Eisenman, RN ;
Bird, A .
NATURE, 1998, 393 (6683) :386-389
[28]   DNA methylation and chromatin modification [J].
Ng, HH ;
Bird, A .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (02) :158-163
[29]  
Nolan K, 1999, MOL CELL BIOL, V19, P6120
[30]   The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway [J].
Okada, S ;
Kao, AW ;
Ceresa, BP ;
Blaikie, P ;
Margolis, B ;
Pessin, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :28042-28049